COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and ...
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US ...
The global innovation stage delivers unprecedented momentum, redefining what's possible across every industry, and revealing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback